KEPSA and MindHYVE.ai Sign Strategic Agreement to Launch National-Scale AGI Workforce, SME, and Innovation Initiatives Across Kenya
NAIROBI, Kenya and NEWPORT BEACH, Calif., July 15, 2025 /PRNewswire/ -- The…
Precipio Enters Into Agreement With Warrant Holder To Exercise Majority Of Warrants As Cashless
NEW HAVEN, Conn., July 11, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics…
Basilea receives USD 39 million funding under BARDA agreement to continue to advance novel antifungals fosmanogepix and BAL2062
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08,…
LENZ Therapeutics and Laboratoires Tha Announce Exclusive License and Commercialization Agreement for LNZ100 in Canada
Exclusive agreement includes over $70 million in upfront and milestone payments to…
ASICS signs official supplier agreement with the Asian Paralympic Committee
ASICS Corporation is pleased to announce the signing of an official supplier…
Theratechnologies enters into Definitive Agreement to be Acquired by CBBiotechnology, an Affiliate of Future Pak
Offer of US$3.01 in cash plus one contingent value right for potential…
Maldives and Henley & Partners Sign Landmark Partnership Agreement to Launch Pioneering Residence by Investment Program
MALÉ, Maldives, July 1, 2025 /PRNewswire/ -- The Government of the Maldives…
Acceleware Announces Agreement for Asset Transfer and New Farmout Opportunity with ONeill Industries International-Canada Inc.
CALGARY, Alberta, June 26, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or…
Acceleware Announces Strategic Collaboration and Distribution Agreement with Scovan
CALGARY, Alberta, June 23, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or…
Parataxis Holdings LLC Announces Definitive Agreement with Bridge Biotherapeutics, Inc. (KOSDAQ: 288330), to Bring Institutionally-Backed, Bitcoin Treasury Company to the South Korean Public Markets:
SEOUL, South Korea and NEW YORK, June 20, 2025 /PRNewswire/ -- Parataxis Holdings…
